| ID | Sequence | Length | GC content |
|---|---|---|---|
| CDKN2B-AS1:59 | AAACCGCUGCACGCCUCUGACGCGACAUCUGGACACGGCGCGGCGCUGG… | 723 nt | 0.4661 |
| CDKN2B-AS1:6 | AGCUACAUCCGUCACCUGACACGGCCCUACCAGGAACAGCCGCGCUCCC… | 1260 nt | 0.4611 |
| CDKN2B-AS1:60 | AAACCGCUGCACGCCUCUGACGCGACAUCUGGACACGGCGCGGCGCUGG… | 710 nt | 0.4535 |
| CDKN2B-AS1:61 | AAACCGCUGCACGCCUCUGACGCGACAUCUGGACACGGCGCGGCGCUGG… | 738 nt | 0.4824 |
| CDKN2B-AS1:62 | AAACCGCUGCACGCCUCUGACGCGACAUCUGGACACGGCGCGGCGCUGG… | 500 nt | 0.4620 |
| CDKN2B-AS1:63 | GACUCCCCUUGAUCCCGCCGCCUGACUCCUCGGCCUGGGAGACAGGAAA… | 445 nt | 0.6719 |
| CDKN2B-AS1:64 | GACUCCCCUUGAUCCCGCCGCCUGACUCCUCGGCGUACGUUCUCUCUCC… | 1772 nt | 0.5226 |
| CDKN2B-AS1:65 | GACUCCCCUUGAUCCCGCCGCCUGACUCCUCGGCGUACGUUCUCUCUCC… | 845 nt | 0.5231 |
| CDKN2B-AS1:66 | GAUCCCGCCGCCUGACUCCUCGGCCUGGGAGACAGGAAAAGCGGUCCUG… | 435 nt | 0.6736 |
| CDKN2B-AS1:67 | AGCUACAUCCGUCACCUGACACGGCCCUACCAGGAACAGCCGCGCUCCC… | 1785 nt | 0.4213 |
This gene is located within the CDKN2B-CDKN2A gene cluster at chromosome 9p21. The gene product is a functional RNA molecule that interacts with polycomb repressive complex-1 (PRC1) and -2 (PRC2), leading to epigenetic silencing of other genes in this cluster. This region is a significant genetic susceptibility locus for cardiovascular disease, and has also been linked to a number of other pathologies, including several cancers, intracranial aneurysm, type-2 diabetes, periodontitis, Alzheimer's disease, endometriosis, frailty in the elderly, and glaucoma. Multiple alternatively processed transcript variants have been detected, some of which may take the form of circular RNA molecules (PMID:21151960). [provided by RefSeq, May 2014]
A study in humans demonstrated that the CDKN2B-AS1 (ANRIL) was significantly upregulated in the plasma of coronary artery disease patients and showed significant diagnostic predictive value with an AUC of 0.82 in ROC analysis [Abdallah et al. DOI:10.1007/s40291-022-00622-1]. A review of studies in humans, mice, and rats indicates that the CDKN2B-AS1 is involved in atherosclerosis formation in coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].